Outcomes	O

The	O
primary	O
efficacy	O
outcome	O
was	O
the	O
proportion	B-PrimaryOutcome
of	I-PrimaryOutcome
subjects	I-PrimaryOutcome
meeting	I-PrimaryOutcome
a	I-PrimaryOutcome
severe	I-PrimaryOutcome
COVID	I-PrimaryOutcome
-	I-PrimaryOutcome
19	I-PrimaryOutcome
progression	I-PrimaryOutcome
composite	I-PrimaryOutcome
end	I-PrimaryOutcome
point	I-PrimaryOutcome
(	I-PrimaryOutcome
death	I-PrimaryOutcome
,	I-PrimaryOutcome
ICU	I-PrimaryOutcome
admission	I-PrimaryOutcome
,	I-PrimaryOutcome
mechanical	I-PrimaryOutcome
ventilation	I-PrimaryOutcome
,	I-PrimaryOutcome
ECMO	I-PrimaryOutcome
,	I-PrimaryOutcome
and	I-PrimaryOutcome
/	I-PrimaryOutcome
or	I-PrimaryOutcome
vasopressor	I-PrimaryOutcome
use	I-PrimaryOutcome
)	I-PrimaryOutcome
at	B-TimeFrame
day	I-TimeFrame
14	I-TimeFrame
.	O

The	O
primary	O
safety	O
outcome	O
was	O
the	O
cumulative	B-OtherOutcome
incidence	I-OtherOutcome
of	I-OtherOutcome
serious	I-OtherOutcome
adverse	I-OtherOutcome
events	I-OtherOutcome
(	I-OtherOutcome
SAEs	I-OtherOutcome
)	I-OtherOutcome
,	I-OtherOutcome
grade	I-OtherOutcome
3	I-OtherOutcome
or	I-OtherOutcome
4	I-OtherOutcome
adverse	I-OtherOutcome
events	I-OtherOutcome
,	I-OtherOutcome
and	I-OtherOutcome
/	I-OtherOutcome
or	I-OtherOutcome
discontinuation	I-OtherOutcome
of	I-OtherOutcome
therapy	I-OtherOutcome
at	B-TimeFrame
day	I-TimeFrame
30	I-TimeFrame
.	O

Secondary	O
clinical	O
outcomes	O
included	O
changes	B-SecondaryOutcome
in	I-SecondaryOutcome
an	I-SecondaryOutcome
8	I-SecondaryOutcome
-	I-SecondaryOutcome
point	I-SecondaryOutcome
ordinal	I-SecondaryOutcome
COVID	I-SecondaryOutcome
-	I-SecondaryOutcome
19	I-SecondaryOutcome
clinical	I-SecondaryOutcome
severity	I-SecondaryOutcome
score	I-SecondaryOutcome
(	O
defined	O
in	O
Table	O
2	O
)	O
,	O
the	O
primary	B-SecondaryOutcome
composite	I-SecondaryOutcome
outcome	I-SecondaryOutcome
and	I-SecondaryOutcome
mortality	I-SecondaryOutcome
at	I-SecondaryOutcome
day	I-SecondaryOutcome
30	I-SecondaryOutcome
,	O
hospital	B-SecondaryOutcome
length	I-SecondaryOutcome
of	I-SecondaryOutcome
stay	I-SecondaryOutcome
(	I-SecondaryOutcome
LOS	I-SecondaryOutcome
)	I-SecondaryOutcome
,	O
fever	B-SecondaryOutcome
-	I-SecondaryOutcome
free	I-SecondaryOutcome
days	I-SecondaryOutcome
,	O
and	O
oxygen	B-SecondaryOutcome
-	I-SecondaryOutcome
free	I-SecondaryOutcome
days	I-SecondaryOutcome
(	B-OutcomeDefinition
defined	I-OutcomeDefinition
as	I-OutcomeDefinition
7	I-OutcomeDefinition
[	I-OutcomeDefinition
the	I-OutcomeDefinition
maximum	I-OutcomeDefinition
number	I-OutcomeDefinition
of	I-OutcomeDefinition
days	I-OutcomeDefinition
with	I-OutcomeDefinition
vital	I-OutcomeDefinition
signs	I-OutcomeDefinition
captured	I-OutcomeDefinition
]	I-OutcomeDefinition
minus	I-OutcomeDefinition
the	I-OutcomeDefinition
number	I-OutcomeDefinition
of	I-OutcomeDefinition
days	I-OutcomeDefinition
with	I-OutcomeDefinition
temperature	I-OutcomeDefinition
≥	I-OutcomeDefinition
100	I-OutcomeDefinition
.	I-OutcomeDefinition
4	I-OutcomeDefinition
°	I-OutcomeDefinition
F	I-OutcomeDefinition
or	I-OutcomeDefinition
requiring	I-OutcomeDefinition
supplemental	I-OutcomeDefinition
oxygen	I-OutcomeDefinition
)	O
.	O

Secondary	O
laboratory	O
outcomes	O
included	O
SARS	B-OtherOutcome
-	I-OtherOutcome
CoV	I-OtherOutcome
-	I-OtherOutcome
2	I-OtherOutcome
viral	I-OtherOutcome
clearance	I-OtherOutcome
on	I-OtherOutcome
nasopharyngeal	I-OtherOutcome
PCR	I-OtherOutcome
,	O
clinically	B-OtherOutcome
significant	I-OtherOutcome
changes	I-OtherOutcome
from	I-OtherOutcome
baseline	I-OtherOutcome
to	I-OtherOutcome
follow	I-OtherOutcome
-	I-OtherOutcome
up	I-OtherOutcome
(	I-OtherOutcome
day	I-OtherOutcome
6	I-OtherOutcome
,	I-OtherOutcome
or	I-OtherOutcome
day	I-OtherOutcome
3	I-OtherOutcome
if	I-OtherOutcome
day	I-OtherOutcome
6	I-OtherOutcome
was	I-OtherOutcome
unavailable	I-OtherOutcome
)	I-OtherOutcome
creatinine	I-OtherOutcome
[	O
25	O
]	O
,	O
hepatic	B-OtherOutcome
and	I-OtherOutcome
hematology	I-OtherOutcome
labs	I-OtherOutcome
[	O
26	O
]	O
,	O
and	O
changes	B-OtherOutcome
in	I-OtherOutcome
inflammatory	I-OtherOutcome
markers	I-OtherOutcome
(	I-OtherOutcome
C	I-OtherOutcome
-	I-OtherOutcome
reactive	I-OtherOutcome
protein	I-OtherOutcome
,	I-OtherOutcome
lactic	I-OtherOutcome
acid	I-OtherOutcome
dehydrogenase	I-OtherOutcome
,	I-OtherOutcome
ferritin	I-OtherOutcome
,	I-OtherOutcome
interleukin	I-OtherOutcome
-	I-OtherOutcome
6	I-OtherOutcome
)	I-OtherOutcome
and	I-OtherOutcome
coagulation	I-OtherOutcome
factors	I-OtherOutcome
(	I-OtherOutcome
D	I-OtherOutcome
-	I-OtherOutcome
dimer	I-OtherOutcome
)	I-OtherOutcome
associated	I-OtherOutcome
with	I-OtherOutcome
severe	I-OtherOutcome
COVID	I-OtherOutcome
-	I-OtherOutcome
19	I-OtherOutcome
[	O
27	O
,	O
28	O
]	O
.	O

